Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-23-060052
Filing Date
2023-03-03
Accepted
2023-03-03 16:17:47
Documents
70
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d468763d10ka.htm   iXBRL 10-K/A 859073
2 EX-23.1 d468763dex231.htm EX-23.1 2526
3 EX-31.1 d468763dex311.htm EX-31.1 6809
4 EX-31.2 d468763dex312.htm EX-31.2 6762
5 EX-32.1 d468763dex321.htm EX-32.1 5568
  Complete submission text file 0001193125-23-060052.txt   5049897

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20221231.xsd EX-101.SCH 40759
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mdgl-20221231_cal.xml EX-101.CAL 42746
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mdgl-20221231_def.xml EX-101.DEF 142574
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20221231_lab.xml EX-101.LAB 354927
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20221231_pre.xml EX-101.PRE 278982
64 EXTRACTED XBRL INSTANCE DOCUMENT d468763d10ka_htm.xml XML 837514
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33277 | Film No.: 23704242
SIC: 2834 Pharmaceutical Preparations